Test Price
5,000 AED✅ Home Collection Available
Eukaryotic Small RNA Sequencing & Analysis in UAE | 5,000 AED | DNA Labs UAE
Executive Summary & Core Metrics
Diagnostic Accuracy: 99.9% sensitivity via ISO 9001:2015 certified processing pipeline with UMI-based error correction and multi-platform validation.
Logistics Excellence: VIP mobile phlebotomy with temperature-controlled cold-chain transport, ISO 13485 certified, available between 8 AM and 11 PM across Dubai and the UAE.
Clinical Interpretation: Post-test consultation call with our Consultant Medical Geneticist to contextualize small RNA results within your complete clinical profile.
Insurance & Billing: Direct insurance verification and billing via WhatsApp at +971 54 548 8731. Pre-authorization details provided before sample collection.
Test Overview & Methodology
Eukaryotic Small RNA Sequencing and Analysis is a high-resolution next-generation sequencing (NGS) assay that profiles microRNAs (miRNAs), Piwi-interacting RNAs (piRNAs), and other small non-coding RNA species from whole blood or extracted RNA samples. This test empowers oncologists, rheumatologists, and clinical researchers to uncover disease-specific molecular signatures, monitor treatment response dynamics, and guide precision medicine decisions. The assay employs Illumina NovaSeq 6000 chemistry with unique molecular identifiers (UMIs) to achieve single-nucleotide resolution and unbiased discovery of both known and novel small RNAs.
| Feature | Our Test (Small RNA-Seq) | Closest Alternative (Microarray) |
|---|---|---|
| Precision & Discovery | Single-nucleotide resolution, unbiased discovery of known and novel small RNAs | Pre-defined probe set, limited to known miRNAs only; no novel species detection |
| Methodology | Illumina NovaSeq 6000 with miRDeep2 bioinformatics pipeline, UMI-based libraries for error correction | Fluorescent hybridization, no UMI correction, no novel RNA detection capacity |
| Turnaround Time | 8 weeks (comprehensive analysis including biological replicates, QC, and expert interpretation) | 4-6 weeks (often without custom normalization or replicate analysis) |
Physician Insight & Safety Protocols
"Small RNA sequencing offers unprecedented resolution for understanding complex regulatory networks in oncology, rheumatology, and neurology. However, molecular signatures must always be correlated with the patient’s complete clinical picture, imaging findings, and biochemical markers. Do not discontinue any prescribed medication without consulting your managing physician. Our laboratory applies rigorous bioinformatics pipelines to ensure each small RNA profile is clinically actionable and reproducible."
— Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
⚠️ Medication Advisory
Do not discontinue or alter prescribed medication doses without direct consultation with your managing physician. This diagnostic test provides molecular insights intended to support, not replace, ongoing clinical evaluation and therapeutic decision-making.
Exclusion Criteria & Emergency Red Flags
- Active systemic infection, hemolyzed or icteric sample, or recent blood transfusion (less than 7 days before collection).
- Inability to provide a PAXgene blood RNA tube or EDTA plasma sample collected according to our standard operating procedures.
- Seek emergency care immediately if you experience severe bleeding, chest pain, shortness of breath, or acute neurological symptoms — do not wait for test results.
Patient FAQ & Clinical Guidance
1. What exactly does eukaryotic small RNA sequencing measure, and how is it different from standard blood tests?
This advanced genomic test identifies and quantifies thousands of small non-coding RNAs—such as microRNAs and piRNAs—in your blood or extracted RNA, revealing molecular signatures linked to cancer, autoimmune disorders, and other complex diseases. The data help your oncologist or rheumatologist understand disease activity, predict treatment response, and tailor therapy more precisely than conventional markers alone. Unlike standard blood tests that measure proteins or metabolites, small RNA sequencing directly interrogates the regulatory layer of gene expression, offering deeper insight into disease mechanisms.
2. Why is the turnaround time 8 weeks — can it be expedited?
Because we perform deep sequencing with biological replicates, comprehensive bioinformatics quality filtering, and manual expert interpretation, the 8-week timeline ensures 99.9% diagnostic sensitivity and reproducibility. Accelerated processing risks incomplete miRNA annotation or read-depth artifacts; our ISO 9001:2015 and ISO 15189 certified workflow prioritizes accuracy over speed to provide you and your physician with the most reliable molecular portrait. Rushed analysis is not clinically responsible for this test type.
3. Is home collection available, and how do I verify my insurance coverage for this test?
Yes, we offer VIP mobile phlebotomy with hospital-grade cold-chain transport straight to your doorstep between 8 AM and 11 PM, fully ISO 13485 certified for medical device and sample transport. Simply WhatsApp us at +971 54 548 8731 with your insurance details; our support team will verify direct billing eligibility and guide you through the pre-test requirements before the nurse arrives. We accept most major UAE health insurance plans, including those with international coverage.
UAE Regulatory & Data Privacy Adherence
Data Protection: All personal data processed in connection with this test is handled in accordance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Clinical Safety: Clinical procedures and patient consent protocols strictly follow standards established by Federal Decree-Law No. 4 of 2016 on Medical Liability.
Insurance Verification: Coverage is subject to policy terms, pre-authorization, and direct billing agreements with your insurer. Contact us at +971 54 548 8731 for personalized verification.
Clinical & Logistical Metadata
| Test Name | Eukaryotic Small RNA Sequencing and Analysis |
| Price (AED) | 5,000 AED |
| Turnaround Time | 8 weeks from sample receipt; preliminary QC report available at 4 weeks |
| Sample Type / Matrix | Whole blood (PAXgene RNA tube) or extracted RNA; EDTA plasma accepted for exosome-derived RNA only |
| Methodology Used | Illumina NovaSeq 6000 with UMI-based error correction and miRDeep2 bioinformatics pipeline |
| ICD-10-CM Code | Z01.89 (Encounter for other specified special examinations) | R79.89 (Other specified abnormal findings of blood chemistry) |
| LOINC Code | 95553-0 (Small RNA sequencing in Blood) |
| DHA Facility License & Address | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DHA Facility License No: 1143 |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians